Torka Robert, Thuma Florian, Herzog Volker, Kirfel Gregor
Institute of Cell Biology, University of Bonn, Ulrich-Haberlandstr. 61a, 53121 Bonn, Germany.
Exp Cell Res. 2006 Nov 15;312(19):3857-71. doi: 10.1016/j.yexcr.2006.08.025. Epub 2006 Sep 3.
For the invasive migration of tumor cells, at least two mechanisms are currently discussed: (1) the mesenchymal mode depending on extracellular proteolysis and (2) the proteolysis-independent amoeboid mode depending on the activity of the Rho kinase ROCK. The ability of tumor cells to switch between different modes of motility has been shown to limit the efficiency of agents aimed to reduce invasion. Here we show by combining 2D and 3D migration assays that human mammary tumor cells exhibited a strongly reduced migration velocity as compared to their normal counterparts indicating that high invasiveness is not necessarily correlated with high migratory capacity in 2D assays. This reduced migration was apparently due to significant differences in actin organization, decreased persistence of lamellipodia by 50% and increased cell substrate adhesion. These differences resulted from a 2.5-fold higher activity of ROCK and were mediated by its downstream effectors myosin light chain kinase and cofilin. Thus, inhibition of ROCK activity caused a marked increase in 2D migration efficiency by 40%, without, however, affecting 3D invasion. A massive reduction of invasion by 60% was achieved by the simultaneous inhibition of the ROCK-dependent amoeboid and the extracellular proteolysis-dependent mesenchymal mode. These results may point to a new efficient strategy for blocking tumor cell invasion in vivo.
对于肿瘤细胞的侵袭性迁移,目前至少讨论了两种机制:(1)依赖细胞外蛋白水解作用的间充质模式,以及(2)依赖Rho激酶ROCK活性的不依赖蛋白水解作用的阿米巴样模式。肿瘤细胞在不同运动模式之间切换的能力已被证明会限制旨在减少侵袭的药物的效率。在这里,我们通过结合二维和三维迁移试验表明,与正常乳腺细胞相比,人乳腺肿瘤细胞的迁移速度大幅降低,这表明在二维试验中,高侵袭性不一定与高迁移能力相关。这种迁移减少显然是由于肌动蛋白组织存在显著差异、片状伪足的持续性降低了50%以及细胞与基质的粘附增加。这些差异是由ROCK活性高2.5倍导致的,并由其下游效应器肌球蛋白轻链激酶和丝切蛋白介导。因此,抑制ROCK活性可使二维迁移效率显著提高40%,但不影响三维侵袭。通过同时抑制依赖ROCK的阿米巴样模式和依赖细胞外蛋白水解作用的间充质模式,侵袭可大幅降低60%。这些结果可能指向一种在体内阻断肿瘤细胞侵袭的新的有效策略。